Lexicon Pharmaceuticals
LXRX
118 hedge funds and large institutions have $1.46B invested in Lexicon Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 13 closing their positions.
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
26% more capital invested
Capital invested by funds: $1.16B → $1.46B (+$298M)
12% more funds holding
Funds holding: 105 → 118 (+13)
3% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 36
3% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $11.3M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13.7M |
| 2 |
CCI
Columbus Circle Investors
|
+$9.32M |
| 3 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
+$7.96M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$7.56M |
| 5 |
Millennium Management
New York
|
+$6.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$13.3M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.45M |
| 3 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$5.37M |
| 4 |
Goldman Sachs
New York
|
-$5.18M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.3M |
LXRX Hedge Fund Activity: Q4 2015 in Review
118 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q4 2015, worth a combined $1.46B — up 26% from $1.16B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new LXRX positions and 13 closed out — a net gain of 13 holders — while 35 added to existing stakes and 36 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $13.7M. The largest seller was State Street, cutting an estimated $13.3M.
- 118 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q4 2015, up from 105 in Q3 2015.
- Funds reported $1.46B of Lexicon Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
- 26 funds opened new Lexicon Pharmaceuticals positions in Q4 2015 and 13 closed out, a net change of +13 holders.
- The largest Lexicon Pharmaceuticals buyer in Q4 2015 was Loomis, Sayles & Company, an estimated $13.7M added.
- The largest Lexicon Pharmaceuticals seller in Q4 2015 was State Street, an estimated $13.3M sold.
Based on aggregated 13F filings for Q4 2015.